Pictet-Spengler类关环反应在新型嘧啶并环分子构架设计与合成中的应用
|
摘要
本论文论述了Pictet-Spengler类关环反应在设计、合成新型嘧啶并环分子构架中的应用,并利用在实验过程中发现的“叔胺效应”参与的串联关环反应合成了7,8,9-三取代二氢嘌呤衍生物。
第一章综述了优势结构、嘧啶并环化合物、苯并二氮化合物和中环化合物在药物设计中的作用及Pictet-Spengler关环反应在有机合成中的应用。
在第二章中,通过对4,5-二氨基-6-氯嘧啶衍生物与醛之间Pictet-Spengler类关环反应的研究,开发了合成新型5,6-二氢-嘧啶并[4,5-b][1,4]苯并二氮化合物、嘧啶并苯并二氮杂环辛烷化合物和嘧啶并吲哚并二氮杂环辛烷化合物分子构架的方法,并且在产物中保留了活性基团,为进一步衍生化,合成药物筛选库打下了基础。
在第三章中,利用在合成嘧啶并中环化合物时发现的竞争反应——“叔胺效应”参与的串联关环反应合成了一系列7,8,9-三取代二氢嘌呤衍生物。
In this dissertation, three novel pyrimidine-fused heterocyclic scaffods were designed and synthesized by using Pictet-Spengler-type cyclization reactions and 7,8,9-trisubstituted dihydropurine derivatives were synthesized via a“tert-Amino Effect”cyclization. These scaffolds are useful in preparation of libraries based on priviledged structures in drug discovery.
In Chapter One, the application of privileged structures, pyrimidine-fused heterocycles, benzodiazepines and medium-sized rings in drug design were reviewed. The Pictet-Spengler-cyclization reactions in organic synthesis and our efforts to develop new synthetic methods to prepare novel pyrimidine-fused heterocyclic scaffolds were summarized.
Priviledged structures represent a class of molecules capable of binding to multiple receptors with high affinity. Design and synthesis of structurally diverse libraries based on privileged structures were an efficient way to discover lead compounds. As a structural component of key biomolecules, pyrimidine moiety has been widely employed in design of privileged structures in medicinal chemistry. Benzodiazepines were first coined as the privileged substructure by Evans et al. in 1988. These compounds show a variety of biological effects predominately ascribed to their actions in the central nervous system. The medium-sized rings are the structural cores of a large number of biologically important natural products and serve as target molecules for numerous synthetic studies. Pictet-Spengler-cyclization reaction was an efficient method in synthesis of tetrahydroisoquinoline and tetrahydro-β-carbolines and has been used to prepare nitrogen containing heterocyclic compounds. The aim and significance of the dissertation were to design and synthesize pyrimidine-fused heterocycles scaffolds via Pictet-Spengler-type cyclization reaction.
In Chapter Two, an efficient method was developed for the construction of novel heterocyclic scaffolds 5,6-dihydropyrimido[4,5-b][1,4]benzodiazepines, 4-chloropyrimido[b,f][1,5]benzodiazocines and pyrimidine-fused indolodiazocines via a Pictet-Spengler-type cyclization reaction. This new method complements the existing chemistries for the preparation of pyrimidine-fused heterocycles derivatives. The resulting compounds may be suitable for further manipulations, such as nucleophilic substitution reactions of the 4-chloro group to yield products with more diversity. Therefore, this new reaction is applicable to the preparation of large libraries of novel scaffolds that are of interest in drug discovery.
The starting pyrimidines 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins were readily prepared by a known two-step process from commercially available 4,6-dichloro-5-nitropyrimidine and N-methylanilines in high yields. The cyclization reactions of 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins with various aldehydes were investigated and these reactions proceeded smoothly to yield products in the presence of excess amount of trifluoroacetic acid. The desired cyclization products were obtained in moderate to excellent yields (44–95%). Higher yields were isolated when electron-withdrawing groups present in aromatic aldehydes, which may be attributed to their higher reactivity towards imine formation and stabilization effect on the imine intermediates. The effect of substituents on the reactivity of precursors was explored by varying its position and changing the electronegativity. Para- and meta-methyl substitutions of the anilino phenyl were well tolerated and the desired cyclized products were isolated in good to excellent yields. However, a para-fluoro substitution led to significant decrease in reaction rate and only 19% of the desired product was isolated after 6 days of reaction. Unfortunately, all attempts on the reactions between 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins and various ketones, such as acetone, butan-2-one and acetophenone, failed to generate the desired products.
As an on-going endeavor to create novel heterocyclic scaffolds we have explored applications of iminium ion cyclization reactions to the synthesis of pyrimidine-fused medium-sized heterocycles. Under the same conditions above, the starting pyrimidines 5-amino-4-(N-alkyllbenzylamino)-6-chloropyrimidins reacted with both aliphatic and aromatic aldehydes. In general, these reactions produced the desired 4-chloropyrimido[b,f][1,5]benzo- diazocines in moderate to good yields(32-90%). When an aliphatic aldehyde was employed, the reaction proceeded faster compared to those with an aromatic aldehyde. This observation could be explained by a previously proposed mechanism that entailed an intramolecular electrophilic substitution of the benzene ring by an iminium ion intermediate. When an aromatic aldehyde was employed, an electron-withdrawing group should decrease the electron-deficiency of the carbonyl, so to decrease the basicity of imine intermediate, which in turn slows down the intramolecular cyclization; while an aliphatic aldehyde forms a more reactive iminium ion for electrophilic substitution. This was supported by the fact that the reactions with aromatic aldehydes bearing an electron-withdrawing group were slower. Higher yields were obtained when electron-withdrawing groups were present in aromatic aldehydes, which may be attributed to their higher reactivity towards imine formation and stabilization effect on the imine intermediates.
However, when the precursor was not electron-rich enough, 7,8,9-trisubstituted dihydropurine derivative was obtained. When we attempted to synthesized the 9-membered pyrimidine fused heterocycles, the desired products was failed to generate and 7,8,9-trisubstituted dihydropurine derivative was obtained.
Based on the results, it was logical to attempt to further expand the scope of this cyclization reaction to 5-amino-4-(N-methyl-(indo-2-yl)-amino)-6-chloropyrimidins and aldehydes. As shown in results, pyrimidine reacted with various aldehydes to produce the desired products in good yields. When an aliphatic aldehyde was employed, the reaction proceeded faster and the yield was higher compared to the ones with an aromatic aldehyde. On the other hand, when an aromatic aldehyde was employed, the yield and the reaction rate were not influenced by electronic properties of its substituents.
In Chapter Three, we reasoned the formation of 7,8,9-trisubstituted dihydropurine derivative was due to the competition of the“tert-amino effect”and applied it to the synthesis of a series of dihydropurine analogs.
The reactions of pyrimidines with aromatic aldehydes proceeded smoothly under trifluoroacetic acid (TFA) conditions to give the desired 7,8,9-trisubstituted dihydropurine derivatives.
It was found that the products were unstable upon standing and preliminary analysis indicated that hydrolysis of the 4-chloro group might be occurring. The replacement of the chloro group by the pyrrolidinyl group led to stablized products.
When R was 4-chloro group, the reaction with an aliphatic aldehyde gave an even more unstable product which might undergo a hydrolysis of the 4-chloro group and oxidation, to lead to a zwitterion compound. The replacement of the chloro group in pyrimidine by the pyrrolidinyl group led to stablized products.
Unfortunately, all attempts on the synthesis of 7,8,9-trisubstituted dihydropurine derivatives with furan and thiophene failed to generate the desired products.
第一章综述了优势结构、嘧啶并环化合物、苯并二氮化合物和中环化合物在药物设计中的作用及Pictet-Spengler关环反应在有机合成中的应用。
在第二章中,通过对4,5-二氨基-6-氯嘧啶衍生物与醛之间Pictet-Spengler类关环反应的研究,开发了合成新型5,6-二氢-嘧啶并[4,5-b][1,4]苯并二氮化合物、嘧啶并苯并二氮杂环辛烷化合物和嘧啶并吲哚并二氮杂环辛烷化合物分子构架的方法,并且在产物中保留了活性基团,为进一步衍生化,合成药物筛选库打下了基础。
在第三章中,利用在合成嘧啶并中环化合物时发现的竞争反应——“叔胺效应”参与的串联关环反应合成了一系列7,8,9-三取代二氢嘌呤衍生物。
In this dissertation, three novel pyrimidine-fused heterocyclic scaffods were designed and synthesized by using Pictet-Spengler-type cyclization reactions and 7,8,9-trisubstituted dihydropurine derivatives were synthesized via a“tert-Amino Effect”cyclization. These scaffolds are useful in preparation of libraries based on priviledged structures in drug discovery.
In Chapter One, the application of privileged structures, pyrimidine-fused heterocycles, benzodiazepines and medium-sized rings in drug design were reviewed. The Pictet-Spengler-cyclization reactions in organic synthesis and our efforts to develop new synthetic methods to prepare novel pyrimidine-fused heterocyclic scaffolds were summarized.
Priviledged structures represent a class of molecules capable of binding to multiple receptors with high affinity. Design and synthesis of structurally diverse libraries based on privileged structures were an efficient way to discover lead compounds. As a structural component of key biomolecules, pyrimidine moiety has been widely employed in design of privileged structures in medicinal chemistry. Benzodiazepines were first coined as the privileged substructure by Evans et al. in 1988. These compounds show a variety of biological effects predominately ascribed to their actions in the central nervous system. The medium-sized rings are the structural cores of a large number of biologically important natural products and serve as target molecules for numerous synthetic studies. Pictet-Spengler-cyclization reaction was an efficient method in synthesis of tetrahydroisoquinoline and tetrahydro-β-carbolines and has been used to prepare nitrogen containing heterocyclic compounds. The aim and significance of the dissertation were to design and synthesize pyrimidine-fused heterocycles scaffolds via Pictet-Spengler-type cyclization reaction.
In Chapter Two, an efficient method was developed for the construction of novel heterocyclic scaffolds 5,6-dihydropyrimido[4,5-b][1,4]benzodiazepines, 4-chloropyrimido[b,f][1,5]benzodiazocines and pyrimidine-fused indolodiazocines via a Pictet-Spengler-type cyclization reaction. This new method complements the existing chemistries for the preparation of pyrimidine-fused heterocycles derivatives. The resulting compounds may be suitable for further manipulations, such as nucleophilic substitution reactions of the 4-chloro group to yield products with more diversity. Therefore, this new reaction is applicable to the preparation of large libraries of novel scaffolds that are of interest in drug discovery.
The starting pyrimidines 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins were readily prepared by a known two-step process from commercially available 4,6-dichloro-5-nitropyrimidine and N-methylanilines in high yields. The cyclization reactions of 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins with various aldehydes were investigated and these reactions proceeded smoothly to yield products in the presence of excess amount of trifluoroacetic acid. The desired cyclization products were obtained in moderate to excellent yields (44–95%). Higher yields were isolated when electron-withdrawing groups present in aromatic aldehydes, which may be attributed to their higher reactivity towards imine formation and stabilization effect on the imine intermediates. The effect of substituents on the reactivity of precursors was explored by varying its position and changing the electronegativity. Para- and meta-methyl substitutions of the anilino phenyl were well tolerated and the desired cyclized products were isolated in good to excellent yields. However, a para-fluoro substitution led to significant decrease in reaction rate and only 19% of the desired product was isolated after 6 days of reaction. Unfortunately, all attempts on the reactions between 5-amino-4-(N-methylphenylamino)-6-chloropyrimidins and various ketones, such as acetone, butan-2-one and acetophenone, failed to generate the desired products.
As an on-going endeavor to create novel heterocyclic scaffolds we have explored applications of iminium ion cyclization reactions to the synthesis of pyrimidine-fused medium-sized heterocycles. Under the same conditions above, the starting pyrimidines 5-amino-4-(N-alkyllbenzylamino)-6-chloropyrimidins reacted with both aliphatic and aromatic aldehydes. In general, these reactions produced the desired 4-chloropyrimido[b,f][1,5]benzo- diazocines in moderate to good yields(32-90%). When an aliphatic aldehyde was employed, the reaction proceeded faster compared to those with an aromatic aldehyde. This observation could be explained by a previously proposed mechanism that entailed an intramolecular electrophilic substitution of the benzene ring by an iminium ion intermediate. When an aromatic aldehyde was employed, an electron-withdrawing group should decrease the electron-deficiency of the carbonyl, so to decrease the basicity of imine intermediate, which in turn slows down the intramolecular cyclization; while an aliphatic aldehyde forms a more reactive iminium ion for electrophilic substitution. This was supported by the fact that the reactions with aromatic aldehydes bearing an electron-withdrawing group were slower. Higher yields were obtained when electron-withdrawing groups were present in aromatic aldehydes, which may be attributed to their higher reactivity towards imine formation and stabilization effect on the imine intermediates.
However, when the precursor was not electron-rich enough, 7,8,9-trisubstituted dihydropurine derivative was obtained. When we attempted to synthesized the 9-membered pyrimidine fused heterocycles, the desired products was failed to generate and 7,8,9-trisubstituted dihydropurine derivative was obtained.
Based on the results, it was logical to attempt to further expand the scope of this cyclization reaction to 5-amino-4-(N-methyl-(indo-2-yl)-amino)-6-chloropyrimidins and aldehydes. As shown in results, pyrimidine reacted with various aldehydes to produce the desired products in good yields. When an aliphatic aldehyde was employed, the reaction proceeded faster and the yield was higher compared to the ones with an aromatic aldehyde. On the other hand, when an aromatic aldehyde was employed, the yield and the reaction rate were not influenced by electronic properties of its substituents.
In Chapter Three, we reasoned the formation of 7,8,9-trisubstituted dihydropurine derivative was due to the competition of the“tert-amino effect”and applied it to the synthesis of a series of dihydropurine analogs.
The reactions of pyrimidines with aromatic aldehydes proceeded smoothly under trifluoroacetic acid (TFA) conditions to give the desired 7,8,9-trisubstituted dihydropurine derivatives.
It was found that the products were unstable upon standing and preliminary analysis indicated that hydrolysis of the 4-chloro group might be occurring. The replacement of the chloro group by the pyrrolidinyl group led to stablized products.
When R was 4-chloro group, the reaction with an aliphatic aldehyde gave an even more unstable product which might undergo a hydrolysis of the 4-chloro group and oxidation, to lead to a zwitterion compound. The replacement of the chloro group in pyrimidine by the pyrrolidinyl group led to stablized products.
Unfortunately, all attempts on the synthesis of 7,8,9-trisubstituted dihydropurine derivatives with furan and thiophene failed to generate the desired products.
引文
[1]郭宗儒,药物分子设计.[M]科学出版: 2005.
[2]王兰明,新药研究开发的途径与方法(上)[J].中国药业2000,9:11-13.
[3] BOHACEK R S, MCMARTIN C, GUIDA W C. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. The art and practice of structure-based drug design: a molecular modeling perspective[J].Medicinal Research Reviews,1996,16:3-50.
[4] KOLB H C, FINN M G, SHARPLESS K B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions[J].Angewandte Chemie International Edition,2001,40:2004-2021.
[5] EVANS B E, RITTLE K E, BOCK M G, et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists[J]. Journal of Medicinal Chemistry,1988,31:2235-2246.
[6] CONVERSO A, BUROW K, MARZINZIK A, et al. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: A Privileged, Bivalent Scaffold for the Display of Nucleophilic Components[J].Journal of Organic Chemistry,2001,66: 4386-4392.
[7] HAJDUK P J, BURES M, PRAESTGAARD J, et al. Privileged Molecules for Protein Binding Identified from NMR-Based Screening[J].Journal of Medicinal Chemistry,2000,43: 3443-3447.
[8] LOWE J A, HAGEMAN D L, DROZDA S E, et al. 5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists[J].Journal of Medicinal Chemistry,1994,37:3789-3811.
[9] MATTER H, BARINGHAUS K -H, NAUMANN T, et al. Computational Approaches Towards the Rational Design of Drug-like Compound Libraries[J].Combinatorial Chemistry & High Throughput Screening,2001,4:453-475.
[10] NICOLAOU K C, PFEFFERKORN J A, BARLUENGA S, et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 3. The "Libraries from Libraries" Principle for Diversity Enhancement of Benzopyran Libraries[J]. Journal of the American Chemical Society,2000,122:9968-9976.
[11] NICOLAOU K C, PFEFFERKORN J A, MITCHELL H J, et al. AFFLECK R L, LILLIG J E. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 2. Construction of a 10 000-Membered Benzopyran Library by Directed Split-and-Pool Chemistry Using NanoKans and Optical Encoding[J]. Journal of the American Chemical Society,2000,122:9954-9967.
[12] SMITH III A B, FAVOR D A, SPRENGELER P A, et al. Molecular modeling, synthesis, and structures of N-methylated 3,5-linked pyrrolin-4-ones toward the creation of a privileged nonpeptide scaffold[J].Bioorganic & Medicinal Chemistry,1999,7:9-22.
[13] ABROUS L, HYNES J, FRIEDRICH S R, et al. Design and Synthesis of Novel Scaffolds for Drug Discovery: Hybrids ofβ-D-Glucose with 1,2,3,4-Tetrahydrobenzo[e][1,4]diazepin-5-one, the Corresponding 1-Oxazepine, and 2- and 4-Pyridyldiazepines[J].Organic Letters,2001,3:1089-1092.
[14] KENNEDY M L, CORTES-SELVA F, PEREZ-VICTORIA J M, et al. Chemosensitization of a Multidrug-Resistant Leishmania tropica Line by New Sesquiterpenes from Maytenus magellanica and Maytenus chubutensis[J]. Journal of Medicinal Chemistry,2001,44:4668-4676.
[15] HIRSCHMANN R, DUCRY L, SMITH A B. Development of an Efficient, Regio- and Stereoselective Route to Libraries Based on theβ-D-Glucose Scaffold[J].Journal of Organic Chemistry,2000,65:8307-8316.
[16] BARAKAT K J, CHENG K, CHAN W W S, et al. Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues[J].Bioorganic & Medicinal Chemistry Letters,1998,8:1431-1436.
[17] HORTON D A, BOURNE G T, SMYTHE M L. The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures[J].Chemical Reviews,2003,103:893-930.
[18] THOMPSON L A, ELLMAN J A. Synthesis and Applications of Small Molecule Libraries[J]. Chemical Reviews,1996,96:555-600.
[19] WANG S, FOLKES A, CHUCKOWREE I, et al. Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance[J].Journal of Medicinal Chemistry,2004,47: 1329-1338.
[20] DING S, GRAY N S, DING Q, et al. Expanding the diversity of purine libraries[J]. Tetrahedron Letters,2001,42:8751-8755.
[21] PERNER R J, GU Y G, LEE C H, et al. 5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase[J]. Journal of Medicinal Chemistry,2003,46:5249-5257.
[22] MCGUIGAN C, PATHIRANA R N, SNOECK R, et al. Discovery of a New Family of Inhibitors of Human Cytomegalovirus (HCMV) Based upon Lipophilic Alkyl Furano Pyrimidine Dideoxy Nucleosides: Action via a Novel Non-Nucleosidic Mechanism[J]. Journal of Medicinal Chemistry,2004,47:1847-1851.
[23] GANGJEE A, ZENG Y, MCGUIRE J J, et al. Synthesis of Classical, Three-Carbon-Bridged 5-Substituted Furo[2,3-d]pyrimidine and 6-Substituted Pyrrolo[2,3-d]pyrimidine Analogues as Antifolates1[J].Journal of Medicinal Chemistry,2004,47:6893-6901.
[24] REWCASTLE G W, BRIDGES A J, FRY D W, et al. Tyrosine Kinase Inhibitors. 12. Synthesis and Structure-Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor[J].Journal of Medicinal Chemistry,1997,40:1820-1826.
[25] GRIFFIN R J, FONTANA G, GOLDING B T, et al. Selective Benzopyranone andPyrimido[2,1-a]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure-Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro[J].Journal of Medicinal Chemistry,2005,48:569-585.
[26]孙居锋,郭志雄,潘惠英, et al.叶酸拮抗剂类药物研究进展[J].化学通报,2006,69:1-12.
[27]仉文升,李安良.药物化学[M].北京:高等教育出版社, 1999.
[28] KOMPIS I M, ISLAM K, THEN R L. DNA and RNA Synthesis: Antifolates[J].Chemical Reviews, 2005,105:593-620.
[29] GANGJEE A, SHI J, QUEENER S F. Synthesis and Biological Activities of Conformationally Restricted, Tricyclic Nonclassical Antifolates as Inhibitors of Dihydrofolate Reductases1[J].Journal of Medicinal Chemistry,1997,40:930-1936.
[30]孙铁民,杨海权,李铣, et al.二氢叶酸还原酶抑制剂溴莫普林的合成[J].中国医药工业杂志2000, 31.
[31] LEE C -H, DAANEN J F, JIANG M, et al. Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors[J].Bioorganic & Medicinal Chemistry Letters,2001,11:2419-2422.
[32] PATRICK D R, HEIMBROOK D C. Protein kinase inhibitors for the treatment of cancer[J]. Drug Discovery Today,1996,1:325-330.
[33] GILL A. Protein kinases in drug discovery and development[J]. Drug Discovery Today, 2004,9:16-17.
[34] SHAWVER L K, LIPSON K E, FONG T A T, et al. Receptor tyrosine kinases as targets for inhibition of angiogenesis[J].Drug Discovery Today,1997,2: 50-63.
[35] BRIDGES A J. Chemical Inhibitors of Protein Kinases[J]. Chemical Reviews,2001,101: 2541-2572.
[36] ARRIS C E, BOYLE F T, CALVERT A H, et al. Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles[J].Journal of Medicinal Chemistry,2000,43:2797-2804.
[37] ECHALIER A, BETTAYEB K, FERANDIN Y, et al. Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex[J].Journal of Medicinal Chemistry,2008,51:737-751.
[38] VANDERWEL S N, HARVEY P J, MCNAMARA D J, et al. Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4[J].Journal of Medicinal Chemistry, 2005,48:2371-2387.
[39] TOOGOOD P L, HARVEY P J, REPINE J T, et al. Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6[J].Journal of Medicinal Chemistry,2005,48:2388-2406.
[40]宫平,赵燕芳.用作细胞周期依赖性蛋白激酶抑制剂的吡唑并嘧啶类衍生物:中国,101054380A[P],2007.
[41] SHOWALTER H D H, BRIDGES A J, ZHOU H, et al. Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and-[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase[J] Journal of Medicinal Chemistry,1999,42:5464-5474.
[42] KLUTCHKO S R, ZHOU H, WINTERS R T, et al. Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors[J].Journal of Medicinal Chemistry,2006,49:1475-1485.
[43] BOCK M G, DIPARDO R M, EVANS B E, et al. Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260[J]. Journal of Medicinal Chemistry,1989,32:13-16.
[44] APPUKKUTTAN P, DEHAEN W, VANDEREYCKEN E. Microwave-Enhanced Synthesis of N-Shifted Buflavine Analogues via a Suzuki-Ring-Closing Metathesis Protocol[J].Organic Letters, 2005,7:2723-2726.
[45] EVANS B E, RITTLE K E, BOCK M G, et al. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists[J].Journal of Medicinal Chemistry,1987,30:1229-1239.
[46] ZHANG S, TONG Y, TIAN M, et al. Dynorphin A as a Potential Endogenous Ligand for Four Members of the Opioid Receptor Gene Family[J].Journal of Pharmacology and Experimental Therapeutics,1998, 286:136-141.
[47] EBERLEIN W G, ENGEL W W, TRUMMLITZ G, et al. Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine[J].Journal of Medicinal Chemistry,1988,31: 1169-1174.
[48] ENGEL W W, EBERLEIN W G, MIHM G, et al. Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics[J].Journal of Medicinal Chemistry,1989,32: 1718-1724.
[49] LENGYEL C, IOST N, VIRAG L, et al. Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QTc and action potential duration[J].British Journal of Pharmacology,2001,132:101-110.
[50] CEPANEC I, LITVIC M, POGORELIC I. Efficient Synthesis of 3-Hydroxy-1,4-benzodiazepines Oxazepam and Lorazepam by New Acetoxylation Reaction of 3-Position of 1,4-Benzodiazepine Ring[J].Organic Process Research & Development,2006,10:1192-1198.
[51] FERRINI S, PONTICELLI F, TADDEI M. Rapid Approach to 3,5-Disubstituted 1,4-Benzodiazepines via the Photo-Fries Rearrangement of Anilides[J].Journal of Organic Chemistry,2006,71:9217-9220.
[52] CARTER M C, ALBER D G, BAXTER R C, et al. 1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus[J]. Journal of Medicinal Chemistry,2006,49:2311-2319.
[53] SEMPLE G, RYDER H, ROOKER D P, et al. (3R)-N-(1-(tert-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist[J].Journal of Medicinal Chemistry,1997,40:331-341.
[54] PLUNKETT M J, ELLMAN J A. Solid-Phase Synthesis of Structurally Diverse 1,4-Benzodiazepine Derivatives Using the Stille Coupling Reaction[J].Journal of the American Chemical Society,1995,117:3306-3307.
[55] PLUNKETT M J, ELLMAN J A. Germanium and Silicon Linking Strategies for Traceless Solid-Phase Synthesis[J].Journal of Organic Chemistry,1997,62:2885-2893.
[56] SAMMAKIA T, SMITH R S. Direct evidence for an oxocarbenium ion intermediate in the asymmetric cleavage of chiral acetals[J].Journal of the American Chemical Society,1992, 114:10998-10999.
[57] IM I, WEBB T R, GONG Y D, et al. Solid-Phase Synthesis of Tetrahydro-1,4-benzodiazepine-2-one Derivatives as aβ-Turn Peptidomimetic Library[J]. Journal of Combinatorial Chemistry,2004,6:207-213.
[58] HONE N D, WILSON W, READER J C. Solid phase synthesis of tetrahydro-1,4-benzodiazepin-2-ones[J]. Tetrahedron Letters,2003,44:8493-8495.
[59] WU Z, ERCOLE F, FITZGERALD M, et al. Synthesis of Tetrahydro-1,4-Benzodiazepine-2-ones on Hydrophilic Polyamide SynPhase Lanterns[J].Journal of Combinatorial Chemistry,2003, 5:166-171.
[60] LAUSTSEN L S, SAMS C K. Parallel Synthesis of 1,3-Dihydro-1,4-benzodiazepine-2-ones Employing Catch and Release[J].Journal of Combinatorial Chemistry,2007,9:1094-1103.
[61] KEATING T A, ARMSTRONG R W. A Remarkable Two-Step Synthesis of Diverse 1,4-Benzodiazepine-2,5-diones Using the Ugi Four-Component Condensation[J]. Journal of Organic Chemistry,1996,61:8935-8939.
[62] SHAABANI A, MALEKI A, MOFAKHAM H. Novel Multicomponent One-Pot Synthesis of Tetrahydro-1H-1,5-benzodiazepine-2-carboxamide Derivatives[J].Journal of Combinatorial Chemistry,2008,10:595-598.
[63] WANG J Y, GUO X F, WANG D X, et al. A New Strategy for the Synthesis of 1,4-Benzodiazepine Derivatives Based on the Tandem N-Alkylation-Ring Opening-Cyclization Reactions of Methyl 1-Arylaziridine-2-carboxylates with N-[2-Bromomethyl(phenyl)]trifluoroacetamides[J].Journal of Organic Chemistry,2008, 73:1979-1982.
[64] KATRITZKY A R, NAIR S K, RODRIGUEZ-GARCIA V, et al. One-Pot Synthesis of 2,4-Benzodiazepin-1-ones Using Benzotriazole Methodology[J].Journal of Organic Chemistry,2002,67:8237-8238.
[65] HU W P, WANG J J, LIN F L, et al. An Efficient Synthesis of Pyrrolo[2,1-c][1,4]benzodiazepine. Synthesis of the Antibiotic DC-81[J].Journal of Organic Chemistry,2001,66:2881-2883.
[66] AQUINO C J, ARMOUR D R, BERMAN J M, et al. Discovery of 1,5-Benzodiazepines with1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist[J].Journal of Medicinal Chemistry,1997,40:331-341.
[54] PLUNKETT M J, ELLMAN J A. Solid-Phase Synthesis of Structurally Diverse 1,4-Benzodiazepine Derivatives Using the Stille Coupling Reaction[J].Journal of the American Chemical Society,1995,117:3306-3307.
[55] PLUNKETT M J, ELLMAN J A. Germanium and Silicon Linking Strategies for Traceless Solid-Phase Synthesis[J].Journal of Organic Chemistry,1997,62:2885-2893.
[56] SAMMAKIA T, SMITH R S. Direct evidence for an oxocarbenium ion intermediate in the asymmetric cleavage of chiral acetals[J].Journal of the American Chemical Society,1992, 114:10998-10999.
[57] IM I, WEBB T R, GONG Y D, et al. Solid-Phase Synthesis of Tetrahydro-1,4-benzodiazepine-2-one Derivatives as aβ-Turn Peptidomimetic Library[J]. Journal of Combinatorial Chemistry,2004,6:207-213.
[58] HONE N D, WILSON W, READER J C. Solid phase synthesis of tetrahydro-1,4-benzodiazepin-2-ones[J]. Tetrahedron Letters,2003,44:8493-8495.
[59] WU Z, ERCOLE F, FITZGERALD M, et al. Synthesis of Tetrahydro-1,4-Benzodiazepine-2-ones on Hydrophilic Polyamide SynPhase Lanterns[J].Journal of Combinatorial Chemistry,2003, 5:166-171.
[60] LAUSTSEN L S, SAMS C K. Parallel Synthesis of 1,3-Dihydro-1,4-benzodiazepine-2-ones Employing Catch and Release[J].Journal of Combinatorial Chemistry,2007,9:1094-1103.
[61] KEATING T A, ARMSTRONG R W. A Remarkable Two-Step Synthesis of Diverse 1,4-Benzodiazepine-2,5-diones Using the Ugi Four-Component Condensation[J]. Journal of Organic Chemistry,1996,61:8935-8939.
[62] SHAABANI A, MALEKI A, MOFAKHAM H. Novel Multicomponent One-Pot Synthesis of Tetrahydro-1H-1,5-benzodiazepine-2-carboxamide Derivatives[J].Journal of Combinatorial Chemistry,2008,10:595-598.
[63] WANG J Y, GUO X F, WANG D X, et al. A New Strategy for the Synthesis of 1,4-Benzodiazepine Derivatives Based on the Tandem N-Alkylation-Ring Opening-Cyclization Reactions of Methyl 1-Arylaziridine-2-carboxylates with N-[2-Bromomethyl(phenyl)]trifluoroacetamides[J].Journal of Organic Chemistry,2008, 73:1979-1982.
[64] KATRITZKY A R, NAIR S K, RODRIGUEZ-GARCIA V, et al. One-Pot Synthesis of 2,4-Benzodiazepin-1-ones Using Benzotriazole Methodology[J].Journal of Organic Chemistry,2002,67:8237-8238.
[65] HU W P, WANG J J, LIN F L, et al. An Efficient Synthesis of Pyrrolo[2,1-c][1,4]benzodiazepine. Synthesis of the Antibiotic DC-81[J].Journal of Organic Chemistry,2001,66:2881-2883.
[66] AQUINO C J, ARMOUR D R, BERMAN J M, et al. Discovery of 1,5-Benzodiazepines with
[82] STARK B P, DUKE A J.[J] Berichte der Deutschen Chemischen Gesellschaft,1894,27:602.
[83] STILLINGS M R, FREEMAN S, MYERS P L, et al. Substituted 5H-dibenz[b,g]-1,4-oxazocines and related amino acids with antiinflammatory activity[J].Journal of Medicinal Chemistry,1985,28:225-233.
[84] ILLUMINATI G, MANDOLINI L. Ring closure reactions of bifunctional chain molecules[J]. Accounts of Chemical Research,1981,14:95-102.
[85] SPRING D R, KRISHNAN S, BLACKWELL H E, et al. Diversity-Oriented Synthesis of Biaryl-Containing Medium Rings Using a One Bead/One Stock Solution Platform[J].Journal of the American Chemical Society,2002,124:1354-1363.
[86] TROST B M. Atom Economy - A Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way[J]. Angewandte Chemie International Edition in English,1995,34:259-281.
[87] RIGBY J H. Transition metal promoted higher-order cycloaddition reactions in organic synthesis[J].Accounts of Chemical Research,1993,26:579-585.
[88] WENDER P A, NUSS M J, SMITH D B, et al. Transition Metal Catalyzed Cycloadditions: An Intramolecular [4 + 4] Cycloaddition Strategy for the Efficient Synthesis of Dicyclopenta[a,d]cyclooctene 5-8-5 Ring Systems[J].Journal of Organic Chemistry,1997,62:4908-4909.
[89] LAUTENS M, TAM W, SOOD C. Enantioselective cobalt-catalyzed [4.pi.+2.pi.+2.pi.] cycloadditions[J].Journal of Organic Chemistry,1993,58:4513-4515.
[90] FELDMAN K S, COME J H, KOSMIDER B J, et al. Mechanistic and preparative studies of the intramolecular photocyclization of methylated 2-(4-pentenyl)tropones[J].Journal of Organic Chemistry,1989,54:592-601.
[91] MASAHIRO MURAKAMI, ITO K I Y. Single-Step Construction of a Nine-Membered Carbocycle by a New [4+4+1] Cycloaddition[J]. Angewandte Chemie International Edition,1998,37: 3418-3420.
[92] MEHTA G, SINGH V. Progress in the Construction of Cyclooctanoid Systems: New Approaches and Applications to Natural Product Syntheses[J].Chemical Reviews,1999,99:881-930.
[93] MOLANDER G A, CAMERON K O. Neighboring group participation in Lewis acid-promoted [3 + 4] and [3 + 5] annulations. The synthesis of oxabicyclo[3.n.1]alkan-3-ones[J]. Journal of the American Chemical Society,1993,115:830-846.
[94] MOLANDER G A, SIEDEM C S. Regioselectivity in [3 + 4] and [3 + 5] Annulation Reactions of Bis(trimethylsilyl) Enol Ethers with Acylsilane Dicarbonyl Dielectrophiles[J]. Journal of Organic Chemistry,1995,60:130-138.
[95] LAVOISIER-GALLO T, CHARONNET E, RODRIGUEZ J. A New Facile Anionic Domino Ring Expansion of Cyclopentanones by Two and Three Carbons for the Flexible Preparation of Functionalized Seven- and Eight-Membered Rings[J].Journal of Organic Chemistry,1998, 63:900-902.
[96] MOLANDER G A, MCKIE A. Synthesis of Substituted Cyclooctanols by a Samarium(II) IodidePromoted 8-Endo Radical Cyclization Process[J].Journal of Organic Chemistry,1994,59:3186-3192.
[97] SWINDELL C S, CHANDER M C, HEERDING J M, et al. An AC --> ABC approach to taxol involving B-ring closure at C-1-C-2[J]. Tetrahedron Letters,1993,34:7005-7008.
[98] SWINDELL C S, CHANDER M C, HEERDING J M, et al. Taxane Synthesis through Intramolecular Pinacol Coupling at C-1-C-2. Construction and Oxidative Transformations of a C-Aromatic Taxane Diene[J].Journal of Organic Chemistry,1996,61:1101-1108.
[99] STAMOS D P, SHENG X C, CHEN S S, et al. Ni(II)/Cr(II)-Mediated Coupling Reaction: Beneficial Effects of 4-tert-Butylpyridine as an Additive and Development of New and Improved Workup Procedures[J]. Tetrahedron Letters,1997,38:6355-6358.
[100] MA S, NEGISHI E -I. Palladium-Catalyzed Cyclization of .omega.-Haloallenes. A New General Route to Common, Medium, and Large Ring Compounds via Cyclic Carbopalladation[J].Journal of the American Chemical Society,1995,117:6345-6357.
[101] WHALEY W M, GOVINDACHARI T R. The Pictet-Spengler Synthesis of Tetrahydroisoquinolines and Related Compounds[M]. In Organic Reactions. John Wiley and Sons: New York, 1951; Vol. VI, p 151.
[102] PICTET A, SPENGLER T.[J].Berichte der Deutschen Chemischen Gesellschaft,1911,44:2030.
[103] YOKOYAMA A, OHWADA T, SHUDO K. Prototype Pictet-Spengler Reactions Catalyzed by Superacids. Involvement of Dicationic Superelectrophiles[J].Journal of Organic Chemistry,1999,64:611-617.
[104] YOUN S W. Development of the Pictet-Spengler Reaction Catalyzed by AuCl3/AgOTf[J]. Journal of Organic Chemistry,2006,71:2521-2523.
[105] TSUJI R, NAKAGAWA M, NISHIDA A. An efficient synthetic approach to optically active [beta]-carboline derivatives via Pictet-Spengler reaction promoted by trimethylchlorosilane[J]. Tetrahedron: Asymmetry,2003,14:177-180.
[106] JAWDOSIUK M, COOK J M. Pictet-Spengler reactions in aprotic media[J].Journal of Organic Chemistry,1984,49:2699-2701.
[107] NIELSEN T E, MELDAL M. Solid-Phase Intramolecular N-Acyliminium Pictet-Spengler Reactions as Crossroads to Scaffold Diversity[J].Journal of Organic Chemistry,2004, 69:3765-3773.
[108] NIELSEN T E, MELDAL M. Solid-Phase Synthesis of Pyrroloisoquinolines via the Intramolecular N-Acyliminium Pictet-Spengler Reaction[J].Journal of Combinatorial Chemistry,2005,7:599-610.
[109] WANG H, GANESAN A. The N-Acyliminium Pictet-Spengler Condensation as a Multicomponent Combinatorial Reaction on Solid Phase and Its Application to the Synthesis of Demethoxyfumitremorgin C Analogues[J].Organic Letters,1999,1:1647-1649.
[110] TAYLOR M S, JACOBSEN E N. Highly Enantioselective Catalytic Acyl-Pictet-Spengler Reactions[J].Journal of the American Chemical Society,2004,126:10558-10559.
[111] SEAYAD J, SEAYAD A M, LIST B. Catalytic Asymmetric Pictet-Spengler Reaction[J].Journal of the American Chemical Society,2006,128:1086-1087.
[112] COX E D, HAMAKER L K, LI J, et al. Enantiospecific Formation of Trans 1,3-Disubstituted Tetrahydro-β-carbolines by the Pictet-Spengler Reaction and Conversion of Cis Diastereomers into Their Trans Counterparts by Scission of the C-1/N-2 Bond[J].Journal of Organic Chemistry,1997,62:44-61.
[113] GAO P, LIU Y, ZHANG L, et al. Total Synthesis of Indole Alkaloid (±)-Subincanadine F via SmI2-Mediated Ring Opening and Bridge-Forming Mannich Reaction[J].Journal of Organic Chemistry,2006,71:9495-9498.
[114] MERGOTT D J, ZUEND S J, JACOBSEN E N. Catalytic Asymmetric Total Synthesis of (+)-Yohimbine[J].Organic Letters,2008,10:745-748.
[115] SHENGULE S R, KARUSO P. Concise Total Synthesis of the Marine Natural Product Ageladine A[J].Organic Letters,2006,8:4083-4084.
[116] ZHENG L, XIANG J, DANG Q, et al. Novel Heterocyclic Scaffold Consisting of Indole-Fused Pteridines[J].Journal of Combinatorial Chemistry,2005,7: 813-815.
[117] ZHENG L, XIANG J, DANG Q, et al. Design and Synthesis of a Tetracyclic Pyrimidine-Fused Benzodiazepine Library[J].Journal of Combinatorial Chemistry,2006, 8:381-387.
[118] METH-COHN O, SUSCHITZKY H. Heterocycles by ring closure of ortho-substituted t-anilines (The t-amino effect) [J].Advances in Heterocyclic Chemistry,1972,14:211.
[119] METH-COHN O. The t-amino effect: heterocycles formed by ring closure of ortho-substituted t-anilines[J].Advances in Heterocyclic Chemistry,1996, 65:1.
[120] PINNOW J, PISTOR G.Berichte der Deutschen Chemischen Gesellschaft,1894,27:602.
[121] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1895,28:3039.
[122] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1897,30:3119.
[123] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1898,31:2982.
[124] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1899,32:1666.
[125] SEHUSTER A, PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1896,29:1053.
[126] OJEA V, PEINADOR C, VILAR J, et al. Formation of New Heterotetracyclic Compounds by Ring Closure of 2-Amino-3-vinylpyridines[J].Synthesis,1993,152.
[127] OJEA V, MUINELO I, FIGUEROA M C, et al. Thermal Isomerization of 4-Amino-3-vinylptridines: Synthesis of Fused 1,6-Naphthyridines and Unexpected New“tert-Amino Effect”Cyclization to Azepines[J].Synlett,1995,622.
[128] OJEA V, MUINELO I, QUINTELA J. Synthesis of fused pyrido[2,3-d]pyrimidines by thermal isomerization of 4-amino-5-vinylpyrimidines[J].Tetrahedron,1998,54:927-934.
[129] CHANTEGREL B, DESHAYES C, FAURE R. Tandem wolff rearrangement-"tert-amino effect" sequence: Synthesis of 2-oxoindolinium enolate and 1H-2-benzopyrane derivatives[J]. Tetrahedron Letters,1995,36:7859-7862.
[130] TVERDOKHLEBOV A V, GORULYA A P, TOLMACHEV A A, et al. A novel tert-amino effect basedapproach to 1,2,3,4-tetrahydroquinoline-2-spirocycloalkanes[J].Tetrahedron,2006,62:9146-9152.
[131] KAVAL N, HALASZ-DAJKA B, VO-THANH G, et al. An efficient microwave-assisted solvent-free synthesis of pyrido-fused ring systems applying the tert-amino effect[J].Tetrahedron,2005,61: 9052-9057.
[132] SCHWART A, BEKE G, KOVáRI Z, et al. Applications of tert-amino effect and a nitrone-olefin 1,3-dipolar cycloaddition reaction: synthesis of novel angularly annelated diazino heterocycles[J]. Journal of Molecular Structure: THEOCHEM 2000,528:49-57.
[133] LIN Y L, HUANG R L, CHANG C M, et al. Two New Puriniums and Three New Pyrimidines from Heterostemma brownii[J].Journal of Natural Products,1997,60:982-985.
[134] HECHT S M, ADAMS B L, KOZARICH J W. Chemical transformations of 7,9-disubstituted purines and related heterocycles. Selective reduction of imines and immonium salts[J]. Journal of Organic Chemistry,1976,41:2303-2311.
[135] KELLEY J L, LINN J A. Synthesis and base-mediated dehydrochlorination of 6-chloro-7,8-dihydro-9-(4-methylbenzyl)-2-(trifluormethyl)purine[J].Journal of Organic Chemistry,1986,51:5435-5436.
[136] BOOTH B L, DIAS A M, PROENCA M F, et al. The Reactions of Diaminomaleonitrile with Isocyanates and Either Aldehydes or Ketones Revisited[J].Journal of Organic Chemistry,2001,66:8436-8441.
[2]王兰明,新药研究开发的途径与方法(上)[J].中国药业2000,9:11-13.
[3] BOHACEK R S, MCMARTIN C, GUIDA W C. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. The art and practice of structure-based drug design: a molecular modeling perspective[J].Medicinal Research Reviews,1996,16:3-50.
[4] KOLB H C, FINN M G, SHARPLESS K B. Click Chemistry: Diverse Chemical Function from a Few Good Reactions[J].Angewandte Chemie International Edition,2001,40:2004-2021.
[5] EVANS B E, RITTLE K E, BOCK M G, et al. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists[J]. Journal of Medicinal Chemistry,1988,31:2235-2246.
[6] CONVERSO A, BUROW K, MARZINZIK A, et al. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: A Privileged, Bivalent Scaffold for the Display of Nucleophilic Components[J].Journal of Organic Chemistry,2001,66: 4386-4392.
[7] HAJDUK P J, BURES M, PRAESTGAARD J, et al. Privileged Molecules for Protein Binding Identified from NMR-Based Screening[J].Journal of Medicinal Chemistry,2000,43: 3443-3447.
[8] LOWE J A, HAGEMAN D L, DROZDA S E, et al. 5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists[J].Journal of Medicinal Chemistry,1994,37:3789-3811.
[9] MATTER H, BARINGHAUS K -H, NAUMANN T, et al. Computational Approaches Towards the Rational Design of Drug-like Compound Libraries[J].Combinatorial Chemistry & High Throughput Screening,2001,4:453-475.
[10] NICOLAOU K C, PFEFFERKORN J A, BARLUENGA S, et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 3. The "Libraries from Libraries" Principle for Diversity Enhancement of Benzopyran Libraries[J]. Journal of the American Chemical Society,2000,122:9968-9976.
[11] NICOLAOU K C, PFEFFERKORN J A, MITCHELL H J, et al. AFFLECK R L, LILLIG J E. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 2. Construction of a 10 000-Membered Benzopyran Library by Directed Split-and-Pool Chemistry Using NanoKans and Optical Encoding[J]. Journal of the American Chemical Society,2000,122:9954-9967.
[12] SMITH III A B, FAVOR D A, SPRENGELER P A, et al. Molecular modeling, synthesis, and structures of N-methylated 3,5-linked pyrrolin-4-ones toward the creation of a privileged nonpeptide scaffold[J].Bioorganic & Medicinal Chemistry,1999,7:9-22.
[13] ABROUS L, HYNES J, FRIEDRICH S R, et al. Design and Synthesis of Novel Scaffolds for Drug Discovery: Hybrids ofβ-D-Glucose with 1,2,3,4-Tetrahydrobenzo[e][1,4]diazepin-5-one, the Corresponding 1-Oxazepine, and 2- and 4-Pyridyldiazepines[J].Organic Letters,2001,3:1089-1092.
[14] KENNEDY M L, CORTES-SELVA F, PEREZ-VICTORIA J M, et al. Chemosensitization of a Multidrug-Resistant Leishmania tropica Line by New Sesquiterpenes from Maytenus magellanica and Maytenus chubutensis[J]. Journal of Medicinal Chemistry,2001,44:4668-4676.
[15] HIRSCHMANN R, DUCRY L, SMITH A B. Development of an Efficient, Regio- and Stereoselective Route to Libraries Based on theβ-D-Glucose Scaffold[J].Journal of Organic Chemistry,2000,65:8307-8316.
[16] BARAKAT K J, CHENG K, CHAN W W S, et al. Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues[J].Bioorganic & Medicinal Chemistry Letters,1998,8:1431-1436.
[17] HORTON D A, BOURNE G T, SMYTHE M L. The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures[J].Chemical Reviews,2003,103:893-930.
[18] THOMPSON L A, ELLMAN J A. Synthesis and Applications of Small Molecule Libraries[J]. Chemical Reviews,1996,96:555-600.
[19] WANG S, FOLKES A, CHUCKOWREE I, et al. Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance[J].Journal of Medicinal Chemistry,2004,47: 1329-1338.
[20] DING S, GRAY N S, DING Q, et al. Expanding the diversity of purine libraries[J]. Tetrahedron Letters,2001,42:8751-8755.
[21] PERNER R J, GU Y G, LEE C H, et al. 5,6,7-Trisubstituted 4-Aminopyrido[2,3-d]pyrimidines as Novel Inhibitors of Adenosine Kinase[J]. Journal of Medicinal Chemistry,2003,46:5249-5257.
[22] MCGUIGAN C, PATHIRANA R N, SNOECK R, et al. Discovery of a New Family of Inhibitors of Human Cytomegalovirus (HCMV) Based upon Lipophilic Alkyl Furano Pyrimidine Dideoxy Nucleosides: Action via a Novel Non-Nucleosidic Mechanism[J]. Journal of Medicinal Chemistry,2004,47:1847-1851.
[23] GANGJEE A, ZENG Y, MCGUIRE J J, et al. Synthesis of Classical, Three-Carbon-Bridged 5-Substituted Furo[2,3-d]pyrimidine and 6-Substituted Pyrrolo[2,3-d]pyrimidine Analogues as Antifolates1[J].Journal of Medicinal Chemistry,2004,47:6893-6901.
[24] REWCASTLE G W, BRIDGES A J, FRY D W, et al. Tyrosine Kinase Inhibitors. 12. Synthesis and Structure-Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor[J].Journal of Medicinal Chemistry,1997,40:1820-1826.
[25] GRIFFIN R J, FONTANA G, GOLDING B T, et al. Selective Benzopyranone andPyrimido[2,1-a]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase: Synthesis, Structure-Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro[J].Journal of Medicinal Chemistry,2005,48:569-585.
[26]孙居锋,郭志雄,潘惠英, et al.叶酸拮抗剂类药物研究进展[J].化学通报,2006,69:1-12.
[27]仉文升,李安良.药物化学[M].北京:高等教育出版社, 1999.
[28] KOMPIS I M, ISLAM K, THEN R L. DNA and RNA Synthesis: Antifolates[J].Chemical Reviews, 2005,105:593-620.
[29] GANGJEE A, SHI J, QUEENER S F. Synthesis and Biological Activities of Conformationally Restricted, Tricyclic Nonclassical Antifolates as Inhibitors of Dihydrofolate Reductases1[J].Journal of Medicinal Chemistry,1997,40:930-1936.
[30]孙铁民,杨海权,李铣, et al.二氢叶酸还原酶抑制剂溴莫普林的合成[J].中国医药工业杂志2000, 31.
[31] LEE C -H, DAANEN J F, JIANG M, et al. Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors[J].Bioorganic & Medicinal Chemistry Letters,2001,11:2419-2422.
[32] PATRICK D R, HEIMBROOK D C. Protein kinase inhibitors for the treatment of cancer[J]. Drug Discovery Today,1996,1:325-330.
[33] GILL A. Protein kinases in drug discovery and development[J]. Drug Discovery Today, 2004,9:16-17.
[34] SHAWVER L K, LIPSON K E, FONG T A T, et al. Receptor tyrosine kinases as targets for inhibition of angiogenesis[J].Drug Discovery Today,1997,2: 50-63.
[35] BRIDGES A J. Chemical Inhibitors of Protein Kinases[J]. Chemical Reviews,2001,101: 2541-2572.
[36] ARRIS C E, BOYLE F T, CALVERT A H, et al. Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles[J].Journal of Medicinal Chemistry,2000,43:2797-2804.
[37] ECHALIER A, BETTAYEB K, FERANDIN Y, et al. Meriolins (3-(Pyrimidin-4-yl)-7-azaindoles): Synthesis, Kinase Inhibitory Activity, Cellular Effects, and Structure of a CDK2/Cyclin A/Meriolin Complex[J].Journal of Medicinal Chemistry,2008,51:737-751.
[38] VANDERWEL S N, HARVEY P J, MCNAMARA D J, et al. Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4[J].Journal of Medicinal Chemistry, 2005,48:2371-2387.
[39] TOOGOOD P L, HARVEY P J, REPINE J T, et al. Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6[J].Journal of Medicinal Chemistry,2005,48:2388-2406.
[40]宫平,赵燕芳.用作细胞周期依赖性蛋白激酶抑制剂的吡唑并嘧啶类衍生物:中国,101054380A[P],2007.
[41] SHOWALTER H D H, BRIDGES A J, ZHOU H, et al. Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and-[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase[J] Journal of Medicinal Chemistry,1999,42:5464-5474.
[42] KLUTCHKO S R, ZHOU H, WINTERS R T, et al. Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors[J].Journal of Medicinal Chemistry,2006,49:1475-1485.
[43] BOCK M G, DIPARDO R M, EVANS B E, et al. Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260[J]. Journal of Medicinal Chemistry,1989,32:13-16.
[44] APPUKKUTTAN P, DEHAEN W, VANDEREYCKEN E. Microwave-Enhanced Synthesis of N-Shifted Buflavine Analogues via a Suzuki-Ring-Closing Metathesis Protocol[J].Organic Letters, 2005,7:2723-2726.
[45] EVANS B E, RITTLE K E, BOCK M G, et al. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists[J].Journal of Medicinal Chemistry,1987,30:1229-1239.
[46] ZHANG S, TONG Y, TIAN M, et al. Dynorphin A as a Potential Endogenous Ligand for Four Members of the Opioid Receptor Gene Family[J].Journal of Pharmacology and Experimental Therapeutics,1998, 286:136-141.
[47] EBERLEIN W G, ENGEL W W, TRUMMLITZ G, et al. Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine[J].Journal of Medicinal Chemistry,1988,31: 1169-1174.
[48] ENGEL W W, EBERLEIN W G, MIHM G, et al. Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics[J].Journal of Medicinal Chemistry,1989,32: 1718-1724.
[49] LENGYEL C, IOST N, VIRAG L, et al. Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QTc and action potential duration[J].British Journal of Pharmacology,2001,132:101-110.
[50] CEPANEC I, LITVIC M, POGORELIC I. Efficient Synthesis of 3-Hydroxy-1,4-benzodiazepines Oxazepam and Lorazepam by New Acetoxylation Reaction of 3-Position of 1,4-Benzodiazepine Ring[J].Organic Process Research & Development,2006,10:1192-1198.
[51] FERRINI S, PONTICELLI F, TADDEI M. Rapid Approach to 3,5-Disubstituted 1,4-Benzodiazepines via the Photo-Fries Rearrangement of Anilides[J].Journal of Organic Chemistry,2006,71:9217-9220.
[52] CARTER M C, ALBER D G, BAXTER R C, et al. 1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus[J]. Journal of Medicinal Chemistry,2006,49:2311-2319.
[53] SEMPLE G, RYDER H, ROOKER D P, et al. (3R)-N-(1-(tert-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist[J].Journal of Medicinal Chemistry,1997,40:331-341.
[54] PLUNKETT M J, ELLMAN J A. Solid-Phase Synthesis of Structurally Diverse 1,4-Benzodiazepine Derivatives Using the Stille Coupling Reaction[J].Journal of the American Chemical Society,1995,117:3306-3307.
[55] PLUNKETT M J, ELLMAN J A. Germanium and Silicon Linking Strategies for Traceless Solid-Phase Synthesis[J].Journal of Organic Chemistry,1997,62:2885-2893.
[56] SAMMAKIA T, SMITH R S. Direct evidence for an oxocarbenium ion intermediate in the asymmetric cleavage of chiral acetals[J].Journal of the American Chemical Society,1992, 114:10998-10999.
[57] IM I, WEBB T R, GONG Y D, et al. Solid-Phase Synthesis of Tetrahydro-1,4-benzodiazepine-2-one Derivatives as aβ-Turn Peptidomimetic Library[J]. Journal of Combinatorial Chemistry,2004,6:207-213.
[58] HONE N D, WILSON W, READER J C. Solid phase synthesis of tetrahydro-1,4-benzodiazepin-2-ones[J]. Tetrahedron Letters,2003,44:8493-8495.
[59] WU Z, ERCOLE F, FITZGERALD M, et al. Synthesis of Tetrahydro-1,4-Benzodiazepine-2-ones on Hydrophilic Polyamide SynPhase Lanterns[J].Journal of Combinatorial Chemistry,2003, 5:166-171.
[60] LAUSTSEN L S, SAMS C K. Parallel Synthesis of 1,3-Dihydro-1,4-benzodiazepine-2-ones Employing Catch and Release[J].Journal of Combinatorial Chemistry,2007,9:1094-1103.
[61] KEATING T A, ARMSTRONG R W. A Remarkable Two-Step Synthesis of Diverse 1,4-Benzodiazepine-2,5-diones Using the Ugi Four-Component Condensation[J]. Journal of Organic Chemistry,1996,61:8935-8939.
[62] SHAABANI A, MALEKI A, MOFAKHAM H. Novel Multicomponent One-Pot Synthesis of Tetrahydro-1H-1,5-benzodiazepine-2-carboxamide Derivatives[J].Journal of Combinatorial Chemistry,2008,10:595-598.
[63] WANG J Y, GUO X F, WANG D X, et al. A New Strategy for the Synthesis of 1,4-Benzodiazepine Derivatives Based on the Tandem N-Alkylation-Ring Opening-Cyclization Reactions of Methyl 1-Arylaziridine-2-carboxylates with N-[2-Bromomethyl(phenyl)]trifluoroacetamides[J].Journal of Organic Chemistry,2008, 73:1979-1982.
[64] KATRITZKY A R, NAIR S K, RODRIGUEZ-GARCIA V, et al. One-Pot Synthesis of 2,4-Benzodiazepin-1-ones Using Benzotriazole Methodology[J].Journal of Organic Chemistry,2002,67:8237-8238.
[65] HU W P, WANG J J, LIN F L, et al. An Efficient Synthesis of Pyrrolo[2,1-c][1,4]benzodiazepine. Synthesis of the Antibiotic DC-81[J].Journal of Organic Chemistry,2001,66:2881-2883.
[66] AQUINO C J, ARMOUR D R, BERMAN J M, et al. Discovery of 1,5-Benzodiazepines with1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): A Potent and Orally Active Gastrin/CCK-B Antagonist[J].Journal of Medicinal Chemistry,1997,40:331-341.
[54] PLUNKETT M J, ELLMAN J A. Solid-Phase Synthesis of Structurally Diverse 1,4-Benzodiazepine Derivatives Using the Stille Coupling Reaction[J].Journal of the American Chemical Society,1995,117:3306-3307.
[55] PLUNKETT M J, ELLMAN J A. Germanium and Silicon Linking Strategies for Traceless Solid-Phase Synthesis[J].Journal of Organic Chemistry,1997,62:2885-2893.
[56] SAMMAKIA T, SMITH R S. Direct evidence for an oxocarbenium ion intermediate in the asymmetric cleavage of chiral acetals[J].Journal of the American Chemical Society,1992, 114:10998-10999.
[57] IM I, WEBB T R, GONG Y D, et al. Solid-Phase Synthesis of Tetrahydro-1,4-benzodiazepine-2-one Derivatives as aβ-Turn Peptidomimetic Library[J]. Journal of Combinatorial Chemistry,2004,6:207-213.
[58] HONE N D, WILSON W, READER J C. Solid phase synthesis of tetrahydro-1,4-benzodiazepin-2-ones[J]. Tetrahedron Letters,2003,44:8493-8495.
[59] WU Z, ERCOLE F, FITZGERALD M, et al. Synthesis of Tetrahydro-1,4-Benzodiazepine-2-ones on Hydrophilic Polyamide SynPhase Lanterns[J].Journal of Combinatorial Chemistry,2003, 5:166-171.
[60] LAUSTSEN L S, SAMS C K. Parallel Synthesis of 1,3-Dihydro-1,4-benzodiazepine-2-ones Employing Catch and Release[J].Journal of Combinatorial Chemistry,2007,9:1094-1103.
[61] KEATING T A, ARMSTRONG R W. A Remarkable Two-Step Synthesis of Diverse 1,4-Benzodiazepine-2,5-diones Using the Ugi Four-Component Condensation[J]. Journal of Organic Chemistry,1996,61:8935-8939.
[62] SHAABANI A, MALEKI A, MOFAKHAM H. Novel Multicomponent One-Pot Synthesis of Tetrahydro-1H-1,5-benzodiazepine-2-carboxamide Derivatives[J].Journal of Combinatorial Chemistry,2008,10:595-598.
[63] WANG J Y, GUO X F, WANG D X, et al. A New Strategy for the Synthesis of 1,4-Benzodiazepine Derivatives Based on the Tandem N-Alkylation-Ring Opening-Cyclization Reactions of Methyl 1-Arylaziridine-2-carboxylates with N-[2-Bromomethyl(phenyl)]trifluoroacetamides[J].Journal of Organic Chemistry,2008, 73:1979-1982.
[64] KATRITZKY A R, NAIR S K, RODRIGUEZ-GARCIA V, et al. One-Pot Synthesis of 2,4-Benzodiazepin-1-ones Using Benzotriazole Methodology[J].Journal of Organic Chemistry,2002,67:8237-8238.
[65] HU W P, WANG J J, LIN F L, et al. An Efficient Synthesis of Pyrrolo[2,1-c][1,4]benzodiazepine. Synthesis of the Antibiotic DC-81[J].Journal of Organic Chemistry,2001,66:2881-2883.
[66] AQUINO C J, ARMOUR D R, BERMAN J M, et al. Discovery of 1,5-Benzodiazepines with
[82] STARK B P, DUKE A J.[J] Berichte der Deutschen Chemischen Gesellschaft,1894,27:602.
[83] STILLINGS M R, FREEMAN S, MYERS P L, et al. Substituted 5H-dibenz[b,g]-1,4-oxazocines and related amino acids with antiinflammatory activity[J].Journal of Medicinal Chemistry,1985,28:225-233.
[84] ILLUMINATI G, MANDOLINI L. Ring closure reactions of bifunctional chain molecules[J]. Accounts of Chemical Research,1981,14:95-102.
[85] SPRING D R, KRISHNAN S, BLACKWELL H E, et al. Diversity-Oriented Synthesis of Biaryl-Containing Medium Rings Using a One Bead/One Stock Solution Platform[J].Journal of the American Chemical Society,2002,124:1354-1363.
[86] TROST B M. Atom Economy - A Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way[J]. Angewandte Chemie International Edition in English,1995,34:259-281.
[87] RIGBY J H. Transition metal promoted higher-order cycloaddition reactions in organic synthesis[J].Accounts of Chemical Research,1993,26:579-585.
[88] WENDER P A, NUSS M J, SMITH D B, et al. Transition Metal Catalyzed Cycloadditions: An Intramolecular [4 + 4] Cycloaddition Strategy for the Efficient Synthesis of Dicyclopenta[a,d]cyclooctene 5-8-5 Ring Systems[J].Journal of Organic Chemistry,1997,62:4908-4909.
[89] LAUTENS M, TAM W, SOOD C. Enantioselective cobalt-catalyzed [4.pi.+2.pi.+2.pi.] cycloadditions[J].Journal of Organic Chemistry,1993,58:4513-4515.
[90] FELDMAN K S, COME J H, KOSMIDER B J, et al. Mechanistic and preparative studies of the intramolecular photocyclization of methylated 2-(4-pentenyl)tropones[J].Journal of Organic Chemistry,1989,54:592-601.
[91] MASAHIRO MURAKAMI, ITO K I Y. Single-Step Construction of a Nine-Membered Carbocycle by a New [4+4+1] Cycloaddition[J]. Angewandte Chemie International Edition,1998,37: 3418-3420.
[92] MEHTA G, SINGH V. Progress in the Construction of Cyclooctanoid Systems: New Approaches and Applications to Natural Product Syntheses[J].Chemical Reviews,1999,99:881-930.
[93] MOLANDER G A, CAMERON K O. Neighboring group participation in Lewis acid-promoted [3 + 4] and [3 + 5] annulations. The synthesis of oxabicyclo[3.n.1]alkan-3-ones[J]. Journal of the American Chemical Society,1993,115:830-846.
[94] MOLANDER G A, SIEDEM C S. Regioselectivity in [3 + 4] and [3 + 5] Annulation Reactions of Bis(trimethylsilyl) Enol Ethers with Acylsilane Dicarbonyl Dielectrophiles[J]. Journal of Organic Chemistry,1995,60:130-138.
[95] LAVOISIER-GALLO T, CHARONNET E, RODRIGUEZ J. A New Facile Anionic Domino Ring Expansion of Cyclopentanones by Two and Three Carbons for the Flexible Preparation of Functionalized Seven- and Eight-Membered Rings[J].Journal of Organic Chemistry,1998, 63:900-902.
[96] MOLANDER G A, MCKIE A. Synthesis of Substituted Cyclooctanols by a Samarium(II) IodidePromoted 8-Endo Radical Cyclization Process[J].Journal of Organic Chemistry,1994,59:3186-3192.
[97] SWINDELL C S, CHANDER M C, HEERDING J M, et al. An AC --> ABC approach to taxol involving B-ring closure at C-1-C-2[J]. Tetrahedron Letters,1993,34:7005-7008.
[98] SWINDELL C S, CHANDER M C, HEERDING J M, et al. Taxane Synthesis through Intramolecular Pinacol Coupling at C-1-C-2. Construction and Oxidative Transformations of a C-Aromatic Taxane Diene[J].Journal of Organic Chemistry,1996,61:1101-1108.
[99] STAMOS D P, SHENG X C, CHEN S S, et al. Ni(II)/Cr(II)-Mediated Coupling Reaction: Beneficial Effects of 4-tert-Butylpyridine as an Additive and Development of New and Improved Workup Procedures[J]. Tetrahedron Letters,1997,38:6355-6358.
[100] MA S, NEGISHI E -I. Palladium-Catalyzed Cyclization of .omega.-Haloallenes. A New General Route to Common, Medium, and Large Ring Compounds via Cyclic Carbopalladation[J].Journal of the American Chemical Society,1995,117:6345-6357.
[101] WHALEY W M, GOVINDACHARI T R. The Pictet-Spengler Synthesis of Tetrahydroisoquinolines and Related Compounds[M]. In Organic Reactions. John Wiley and Sons: New York, 1951; Vol. VI, p 151.
[102] PICTET A, SPENGLER T.[J].Berichte der Deutschen Chemischen Gesellschaft,1911,44:2030.
[103] YOKOYAMA A, OHWADA T, SHUDO K. Prototype Pictet-Spengler Reactions Catalyzed by Superacids. Involvement of Dicationic Superelectrophiles[J].Journal of Organic Chemistry,1999,64:611-617.
[104] YOUN S W. Development of the Pictet-Spengler Reaction Catalyzed by AuCl3/AgOTf[J]. Journal of Organic Chemistry,2006,71:2521-2523.
[105] TSUJI R, NAKAGAWA M, NISHIDA A. An efficient synthetic approach to optically active [beta]-carboline derivatives via Pictet-Spengler reaction promoted by trimethylchlorosilane[J]. Tetrahedron: Asymmetry,2003,14:177-180.
[106] JAWDOSIUK M, COOK J M. Pictet-Spengler reactions in aprotic media[J].Journal of Organic Chemistry,1984,49:2699-2701.
[107] NIELSEN T E, MELDAL M. Solid-Phase Intramolecular N-Acyliminium Pictet-Spengler Reactions as Crossroads to Scaffold Diversity[J].Journal of Organic Chemistry,2004, 69:3765-3773.
[108] NIELSEN T E, MELDAL M. Solid-Phase Synthesis of Pyrroloisoquinolines via the Intramolecular N-Acyliminium Pictet-Spengler Reaction[J].Journal of Combinatorial Chemistry,2005,7:599-610.
[109] WANG H, GANESAN A. The N-Acyliminium Pictet-Spengler Condensation as a Multicomponent Combinatorial Reaction on Solid Phase and Its Application to the Synthesis of Demethoxyfumitremorgin C Analogues[J].Organic Letters,1999,1:1647-1649.
[110] TAYLOR M S, JACOBSEN E N. Highly Enantioselective Catalytic Acyl-Pictet-Spengler Reactions[J].Journal of the American Chemical Society,2004,126:10558-10559.
[111] SEAYAD J, SEAYAD A M, LIST B. Catalytic Asymmetric Pictet-Spengler Reaction[J].Journal of the American Chemical Society,2006,128:1086-1087.
[112] COX E D, HAMAKER L K, LI J, et al. Enantiospecific Formation of Trans 1,3-Disubstituted Tetrahydro-β-carbolines by the Pictet-Spengler Reaction and Conversion of Cis Diastereomers into Their Trans Counterparts by Scission of the C-1/N-2 Bond[J].Journal of Organic Chemistry,1997,62:44-61.
[113] GAO P, LIU Y, ZHANG L, et al. Total Synthesis of Indole Alkaloid (±)-Subincanadine F via SmI2-Mediated Ring Opening and Bridge-Forming Mannich Reaction[J].Journal of Organic Chemistry,2006,71:9495-9498.
[114] MERGOTT D J, ZUEND S J, JACOBSEN E N. Catalytic Asymmetric Total Synthesis of (+)-Yohimbine[J].Organic Letters,2008,10:745-748.
[115] SHENGULE S R, KARUSO P. Concise Total Synthesis of the Marine Natural Product Ageladine A[J].Organic Letters,2006,8:4083-4084.
[116] ZHENG L, XIANG J, DANG Q, et al. Novel Heterocyclic Scaffold Consisting of Indole-Fused Pteridines[J].Journal of Combinatorial Chemistry,2005,7: 813-815.
[117] ZHENG L, XIANG J, DANG Q, et al. Design and Synthesis of a Tetracyclic Pyrimidine-Fused Benzodiazepine Library[J].Journal of Combinatorial Chemistry,2006, 8:381-387.
[118] METH-COHN O, SUSCHITZKY H. Heterocycles by ring closure of ortho-substituted t-anilines (The t-amino effect) [J].Advances in Heterocyclic Chemistry,1972,14:211.
[119] METH-COHN O. The t-amino effect: heterocycles formed by ring closure of ortho-substituted t-anilines[J].Advances in Heterocyclic Chemistry,1996, 65:1.
[120] PINNOW J, PISTOR G.Berichte der Deutschen Chemischen Gesellschaft,1894,27:602.
[121] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1895,28:3039.
[122] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1897,30:3119.
[123] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1898,31:2982.
[124] PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1899,32:1666.
[125] SEHUSTER A, PINNOW J. Berichte der Deutschen Chemischen Gesellschaft,1896,29:1053.
[126] OJEA V, PEINADOR C, VILAR J, et al. Formation of New Heterotetracyclic Compounds by Ring Closure of 2-Amino-3-vinylpyridines[J].Synthesis,1993,152.
[127] OJEA V, MUINELO I, FIGUEROA M C, et al. Thermal Isomerization of 4-Amino-3-vinylptridines: Synthesis of Fused 1,6-Naphthyridines and Unexpected New“tert-Amino Effect”Cyclization to Azepines[J].Synlett,1995,622.
[128] OJEA V, MUINELO I, QUINTELA J. Synthesis of fused pyrido[2,3-d]pyrimidines by thermal isomerization of 4-amino-5-vinylpyrimidines[J].Tetrahedron,1998,54:927-934.
[129] CHANTEGREL B, DESHAYES C, FAURE R. Tandem wolff rearrangement-"tert-amino effect" sequence: Synthesis of 2-oxoindolinium enolate and 1H-2-benzopyrane derivatives[J]. Tetrahedron Letters,1995,36:7859-7862.
[130] TVERDOKHLEBOV A V, GORULYA A P, TOLMACHEV A A, et al. A novel tert-amino effect basedapproach to 1,2,3,4-tetrahydroquinoline-2-spirocycloalkanes[J].Tetrahedron,2006,62:9146-9152.
[131] KAVAL N, HALASZ-DAJKA B, VO-THANH G, et al. An efficient microwave-assisted solvent-free synthesis of pyrido-fused ring systems applying the tert-amino effect[J].Tetrahedron,2005,61: 9052-9057.
[132] SCHWART A, BEKE G, KOVáRI Z, et al. Applications of tert-amino effect and a nitrone-olefin 1,3-dipolar cycloaddition reaction: synthesis of novel angularly annelated diazino heterocycles[J]. Journal of Molecular Structure: THEOCHEM 2000,528:49-57.
[133] LIN Y L, HUANG R L, CHANG C M, et al. Two New Puriniums and Three New Pyrimidines from Heterostemma brownii[J].Journal of Natural Products,1997,60:982-985.
[134] HECHT S M, ADAMS B L, KOZARICH J W. Chemical transformations of 7,9-disubstituted purines and related heterocycles. Selective reduction of imines and immonium salts[J]. Journal of Organic Chemistry,1976,41:2303-2311.
[135] KELLEY J L, LINN J A. Synthesis and base-mediated dehydrochlorination of 6-chloro-7,8-dihydro-9-(4-methylbenzyl)-2-(trifluormethyl)purine[J].Journal of Organic Chemistry,1986,51:5435-5436.
[136] BOOTH B L, DIAS A M, PROENCA M F, et al. The Reactions of Diaminomaleonitrile with Isocyanates and Either Aldehydes or Ketones Revisited[J].Journal of Organic Chemistry,2001,66:8436-8441.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |